UKI

N-(2-(dimethylamino)ethyl)-1-(3-((4-((2-methyl-1H-indol-5-yl)oxy)pyrimidin-2-yl)amino)phenyl)methanesulfonamide


Toggle HydrogenToggle Labels

Chemical Component Summary

NameN-(2-(dimethylamino)ethyl)-1-(3-((4-((2-methyl-1H-indol-5-yl)oxy)pyrimidin-2-yl)amino)phenyl)methanesulfonamide
SynonymsSulfatinib
Identifiers~{N}-[2-(dimethylamino)ethyl]-1-[3-[[4-[(2-methyl-1~{H}-indol-5-yl)oxy]pyrimidin-2-yl]amino]phenyl]methanesulfonamide
FormulaC24 H28 N6 O3 S
Molecular Weight480.583
TypeNON-POLYMER
Isomeric SMILESCc1cc2cc(ccc2[nH]1)Oc3ccnc(n3)Nc4cccc(c4)CS(=O)(=O)NCCN(C)C
InChIInChI=1S/C24H28N6O3S/c1-17-13-19-15-21(7-8-22(19)27-17)33-23-9-10-25-24(29-23)28-20-6-4-5-18(14-20)16-34(31,32)26-11-12-30(2)3/h4-10,13-15,26-27H,11-12,16H2,1-3H3,(H,25,28,29)
InChIKeyTTZSNFLLYPYKIL-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count62
Chiral Atom Count0
Bond Count65
Aromatic Bond Count22

Drug Info: DrugBank

DrugBank IDDB15106 
NameSurufatinib
Groups investigational
DescriptionSurufatinib is under investigation in clinical trial NCT02588170 (Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors).
Synonyms
  • Surufatinib
  • SULFATINIB
Categories
  • Amides
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • Heterocyclic Compounds, Fused-Ring
  • Protein Kinase Inhibitors
ATC-CodeL01EX24
CAS number1308672-74-3

Related Resource References

Resource NameReference
PubChem 52920501
ChEMBL CHEMBL4297190